We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-13.65%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.97B
AUM Growth
-$1.21B
Cap. Flow
+$169M
Cap. Flow %
2.12%
Top 10 Hldgs %
71.87%
Holding
92
New
8
Increased
40
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$21.5M
2
PRVA icon
Privia Health
PRVA
+$17M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$15.2M
4
HDB icon
HDFC Bank
HDB
+$15M
5
MSFT icon
Microsoft
MSFT
+$9.84M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$10.2M
2
TXMD icon
TherapeuticsMD
TXMD
+$2.35M
3
EA icon
Electronic Arts
EA
+$1.61M
4
TCOM icon
Trip.com Group
TCOM
+$1.1M
5
SE icon
Sea Limited
SE
+$1.03M

Sector Composition

Rank Sector Weight
1 Healthcare 17.25%
2 Financials 16.88%
3 Technology 16.88%
4 Consumer Discretionary 15.11%
5 Communication Services 10.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISRG icon
26
Intuitive Surgical
ISRG
$128B
$22.2M 0.28%
110,811
– –
AXNX
27
DELISTED
Axonics, Inc. Common Stock
AXNX
$21.6M 0.27%
380,400
– –
DXCM icon
28
DexCom
DXCM
$29.2B
$21M 0.26%
282,000
+50,000
+22% +$4.56M
NVCR icon
29
NovoCure
NVCR
$1.81B
$20.6M 0.26%
296,784
– –
PRVA icon
30
Privia Health
PRVA
$3.09B
$19.5M 0.24%
+670,000
New +$17M
BMRN icon
31
BioMarin Pharmaceuticals
BMRN
$12B
$17.7M 0.22%
213,851
– –
EXAS
32
DELISTED
Exact Sciences
EXAS
$17.7M 0.22%
448,894
+108,689
+32% +$5.81M
INFY icon
33
Infosys
INFY
$50.6B
$15.6M 0.2%
841,644
+192,372
+30% +$3.83M
ALGN icon
34
Align Technology
ALGN
$12.9B
$15M 0.19%
63,428
– –
KRYS icon
35
Krystal Biotech
KRYS
$10.6B
$14.8M 0.19%
225,809
– –
TFX icon
36
Teleflex
TFX
$5.85B
$14.3M 0.18%
58,000
– –
PODD icon
37
Insulet
PODD
$11.7B
$13.7M 0.17%
62,908
– –
BHVN
38
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$13.5M 0.17%
92,498
-80,000
-46% -$10.2M
IOVA icon
39
Iovance Biotherapeutics
IOVA
$2.03B
$12.8M 0.16%
+1,160,000
New +$15.2M
OSH
40
DELISTED
Oak Street Health, Inc.
OSH
$11.6M 0.15%
704,933
– –
OM icon
41
Outset Medical
OM
$87.3M
$11.1M 0.14%
+50,000
New +$21.5M
SCI icon
42
Service Corp International
SCI
$11.7B
$11M 0.14%
158,808
-3,530
-2% -$241K
ILMN icon
43
Illumina
ILMN
$29.2B
$10.7M 0.13%
59,601
– –
QDEL icon
44
QuidelOrtho
QDEL
$1.13B
$9.72M 0.12%
100,000
– –
SRPT icon
45
Sarepta Therapeutics
SRPT
$1.62B
$9.02M 0.11%
120,329
– –
GKOS icon
46
Glaukos
GKOS
$9.19B
$8.96M 0.11%
197,212
– –
WAT icon
47
Waters Corp
WAT
$37.6B
$8.85M 0.11%
26,748
+2,762
+12% +$877K
AERI
48
DELISTED
Aerie Pharmaceuticals
AERI
$8.67M 0.11%
1,156,142
– –
IRTC icon
49
iRhythm Holdings
IRTC
$3.94B
$8.64M 0.11%
80,000
– –
SNPS icon
50
Synopsys
SNPS
$73.1B
$8.55M 0.11%
28,148
+2,907
+12% +$877K
1
2
3 4

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2022 Portfolio in Review

As of Q2 2022, C WorldWide Group held 92 positions worth $7.97B, down 13% from $9.18B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

C WorldWide Group's Q2 2022 filing shows 8 new, 40 increased, 6 reduced and 1 closed positions. Its largest new stake was Outset Medical: 50,000 shares worth $11.1M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • C WorldWide Group's largest Q2 2022 buy was Outset Medical: 50,000 shares worth $11.1M.
  • C WorldWide Group added most to HDFC Bank in Q2 2022, an estimated $15M increase.
  • C WorldWide Group's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $10.2M.
  • C WorldWide Group fully exited TherapeuticsMD in Q2 2022, selling an estimated $2.35M.
  • C WorldWide Group's ten largest holdings make up 72% of its $7.97B portfolio in Q2 2022.
  • C WorldWide Group opened 8 new positions and closed 1 in Q2 2022.
  • C WorldWide Group's portfolio value fell 13% quarter-over-quarter to $7.97B.

Based on C WorldWide Group's 13F filing for Q2 2022, filed 2 Aug 2022.